Gene · 2494
Papers1,984
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,984
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Targeting the tumor microenvironment for effective treatment of gastrointestinal cancers. | Front Endocrinol (Lausanne) | 2025 | 40370781 | PubTator, text mining | PubMed |
| ATF1 and miR-27b-3p drive intervertebral disc degeneration through the PPARG/NF-κB signaling axis. | Commun Biol | 2025 | 40369110 | PubTator, text mining | PubMed |
| Abnormal phosphorylation of human LRH1 at Ser510 predicts poor prognosis and promotes cell viability in lung squamous cell carcinoma. | BMC Cancer | 2025 | 40269773 | PubTator, text mining | PubMed |
| Deciphering Sequence Determinants of Zygotic Genome Activation Genes: Insights From Machine Learning and the ZGAExplorer Platform. | Cell Prolif | 2025 | 40251810 | PubTator, text mining | PubMed |
| The self-renewal function of Oct-4 can be replaced by the EWS-Oct-4 fusion protein in embryonic stem cells. | Cell Mol Life Sci | 2025 | 40251420 | PubTator, text mining | PubMed |
| Fragment-Based Discovery of Drug-like LRH-1 Agonists. | ACS Med Chem Lett | 2025 | 40236550 | PubTator, text mining | PubMed |
| Effects of hydroxypropyl starch on intestinal health and transcriptome of geese. | Sci Rep | 2025 | 40210970 | PubTator, text mining | PubMed |
| CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin. | Clin Transl Sci | 2025 | 40146606 | PubTator, text mining | PubMed |
| Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 Modulators. | ACS Pharmacol Transl Sci | 2025 | 40109748 | PubTator, text mining | PubMed |
| Research and progress of microRNA-136 in metastatic tumors. | Front Oncol | 2025 | 40104500 | PubTator, text mining | PubMed |
| Pathogenesis and Management of Intestinal Failure-Associated Liver Disease. | Semin Liver Dis | 2025 | 40015320 | PubTator, text mining | PubMed |
| Impact of Adverse Childhood Experiences (ACE) and Childhood Protective Factors (CPF) on physical and mental health of medical students of a public sector medical university. | PLOS Glob Public Health | 2025 | 39992907 | PubTator, text mining | PubMed |
| Understanding Genetic Regulation of Sex Differentiation in Hermaphroditic Fish. | Animals (Basel) | 2025 | 39858119 | PubTator, text mining | PubMed |
| Genome-Wide Screening in Haploid Stem Cells Reveals Synthetic Lethality Targeting MLH1 and TP53 Deficient Tumours. | Cell Prolif | 2025 | 39814695 | PubTator, text mining | PubMed |
| Correction to "NR5A2 Promotes Malignancy Progression and Mediates the Effect of Cisplatin in Cutaneous Squamous Cell Carcinoma". | Immun Inflamm Dis | 2025 | 39807760 | PubTator, text mining | PubMed |
| An animal model recapitulates human hepatic diseases associated with GATA6 mutations. | Proc Natl Acad Sci U S A | 2025 | 39739787 | PubTator, text mining | PubMed |
| Deciphering significant interaction between Clp1 (CF IA) and Ssu72 (CPF) in pre-mRNA processing via in silico approaches. | J Biomol Struct Dyn | 2025 | 39522172 | PubTator, text mining | PubMed |
| Rise and SINE: roles of transcription factors and retrotransposons in zygotic genome activation. | Nat Rev Mol Cell Biol | 2025 | 39358607 | PubTator, text mining | PubMed |
| Fateful Decisions of Where to Cut the Line: Pathology Associated with Aberrant 3' End Processing and Transcription Termination. | J Mol Biol | 2025 | 39321865 | PubTator, text mining | PubMed |
| Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver disease. | NPJ Metab Health Dis | 2024 | 40603501 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2494/papers?page=3